Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Jacobs syndrome 1 Gastrointestinal Neoplasms 1

Interventions

pembrolizumab 1280 Specimen Handling 928 Carboplatin 836 Magnetic Resonance Spectroscopy 831 Cyclophosphamide 807 Cisplatin 735 Nivolumab 679 Paclitaxel 634 Radiotherapy 617 Gemcitabine 579 Biopsy 560 Bevacizumab 486 Dexamethasone 444 fludarabine 409 Docetaxel 385 venetoclax 372 Oxaliplatin 367 Capecitabine 363 Fluorouracil 358 atezolizumab 353 durvalumab 339 Rituximab 335 Drug Therapy 333 Radiosurgery 321 Doxorubicin 320 Blood Specimen Collection 315 Standard of Care 311 Pemetrexed 308 Ipilimumab 303 Radiation 289

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

avatrombopag × 1 year × Clear all

NCT05772546 2026-03-13

ACT-GI

Massachusetts General Hospital

Phase 2 Active not recruiting

Gastrointestinal

Jacobs syndrome, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡